Læknablaðið - 15.08.1993, Síða 30

236
LÆKNABLAÐIÐ
11. Editorial. Hepatitis A: a vaccine at Iast. Lancet 1992;
339: 1198-9.
12. Briem H, Wynen Y, Safary A. Immunogenicity and
reactogenicity of hepatitis A vaccine administered as
a single dose with a booster at 6 months. Abstract
048. Eighth Triennial Symposium on Viral Hepatitis
and Liver Diseases, Tokyo, May 10-14, 1993.
13. Jónasson JL. Hepatitis B antigen. Læknablaðið 1977;
63: 3-17.
14. Guðmundsson S, Jensson Ó. Hepatitis B markers
among blood donors in Iceland. Læknablaðið 1978;
64: 91-5.
15. Briem H, Weiland O, Einarsson ET, Von Sydow M.
Prevalence of hepatitis B virus markers in Icelandic
outpatients and hospital personnel in 1979 and in
1987. Scand J Infect Dis 1990; 22: 149-53.
16. Feitelson M. Hepatitis B virus infection and primary
hepatocellular carcinoma. Clin Microbiol Rev 1992;
5: 275-301.
17. Thorgeirsson O, Björnsson J. Hepatocellular
carcinoma: observations in a population with low
incidence of hepatitis and cirrhosis. Manuscript, 1990.
18. Hoofnagle JH, Peters M, Mullen KD, et al.
Randomized, controlled trial of recombinant human
alfa-interferon treatment in patients with chronic
hepatitis B. Gastroenterology 1988; 95: 1318-25.
19. Rizzetto M, Canese MG, Arico S, et al.
Immunofluorescence detection of new antigen-
antibody system (delta-antidelta) associated to
hepatitis B virus in liver and in serum of HBsAg
carriers. Gut 1977; 18: 997-1003.
20. Hansson BG, Moestrup T, Widell A, Nordenfelt E.
Infection with the delta agent in Sweden: introduction
of a new hepatitis agent. J Infect Dis 1982; 146: 472-
8.
21. Briem H. Mótefni gegn deltaveiru. Úrtakskönnun
meðal þeirra sem smitast hafa af lifrarbólguveiru B á
íslandi á árunum 1986-92. Óbirtar niðurstöður.
22. Choo Q-L, Kuo G, Weincr AJ, Overby LR, Bradley
DW, Houghton M. Isolation of a cDNA code derived
from a blood-borne non-A, non-B viral hepatitis
genome. Sience 1989; 244: 359-62.
23. Smáradóttir A, Þorsteinsson SB, Erlingsson SI,
Löve A, Jónasson JG, Harðarson BG. Skimun fyrir
hepatitis C hjá Blóðbankanum. I4:e Nordiska Mötet i
Transfusionsmedicin, 3-6 juni 1993, Reykjavík.
24. Brient H. Óbirtar rannsóknir á algengi lifrarbólgu C á
Islandi.
25. Briem H, Guðmundsson S. Ársskýrsla Borgarspítalans
1992.
26. Snorrason GJ. Sigurðarson SÞ, Guðmundsson
S, Briem H. Óskir um mótefnamælingu gegn
alnæmisveiru: Áhættuþættir smits og algengi
mótefna gegn alnæmisveiru, lifrarbólguveiru B og
C. Læknablaðið 1993; 79: 5-9.
27. Alter HJ. Post-tranfusion hepatitis (PTH) in the
United States. Eighth Triennial Symposium on Viral
Hepatitis and Liver Diseases, Tokyo, May 10-14,
1993.
28. Tanaka K, Hirhata T, Koga S, et al. Hepatitis C
and hepatitis B in the etiology of hepatocellular
carcinoina in the Japanese population. Cancer Res
1991; 51: 2842-7.
29. Verbaan H, Widell A, Lindgren S, Lindmark B,
Nordenfelt E, Eriksson S. Hepatitis C in chronic
liver disease: an epidemiological study based on 566
consecutive patients undergoing liverþiopsies under a
10 years period. J Intern Med 1992; 232: 33-42.
30. Hoofnagle JH, Mullen KD, Jones DB, et al.
Treatment of chronic non A, non B hepatitis with
recombinant alpha interferon: a preliminary report. N
Engl J Med 1986; 315: 1575-8.
31. Krawczynski K, Bradley DW. Enterically transmitted
non-A, non-B hepatitis: identification of virus-
associated antigen in experimentally infected
cynomologus macaques. J Infect Dis 1989; 159:
1042-9.
32. Favorov MO, Fields HA, Purdy MA, et al. Serologic
identification of hepatitis E virus infections in
epidemic and endemic settings. J Med Virol 1992;
36: 246-50.
33. Khuroo MS, Teli MR, Skidmore S, et al. Incidence
and severity of viral hepatitis in pregnancy. Am J
Med 1981; 70: 252.
34. Fagan EA. Harrison TJ. Candidate hepatitis F
virus in sporadic non-A, non-B acute liver failure:
exclusion in liver of hepatitis A to E by polymerase
chain reaction. Abstract 721. Eighth Triennial
Symposiumon Viral Hepatitis and Liver Diseases,
Tokyo, May 10-14, 1993.